← Back to Search

Nonablative Laser

Laser Therapy for Male Pattern Baldness and Scarring Alopecia

N/A
Recruiting
Led By Kseniya Kobets, MD
Research Sponsored by Montefiore Medical Center
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Subjects with diagnosis of biopsy proven androgenetic alopecia or scarring alopecia with hair loss recorded over the past 6 months
Be older than 18 years old
Must not have
History or current use of immunosuppressive medications/biologics, 6 months prior to and during the study
Any previous surgical procedure in the treatment area in the past 12 months, or major surgery in the last 6 months
Timeline
Screening 3 weeks
Treatment Varies
Follow Up month 15
Awards & highlights

Summary

This trialtested a laser to treat two types of hair loss: androgenetic & scarring alopecia.

Who is the study for?
This trial is for healthy adults over 18 with a confirmed diagnosis of androgenetic alopecia or scarring alopecia, who have experienced hair loss in the last 6 months. Participants must not smoke, should agree to maintain their current hair care routine without changes, and cannot have used certain hair loss treatments recently.
What is being tested?
The study tests a non-ablative 1470 nm laser (Sciton HALO) on individuals with specific types of hair loss. It's an open-label pilot study where all participants receive the same treatment to see if it improves their condition.
What are the potential side effects?
While specific side effects are not listed here, similar laser treatments may cause skin irritation, redness, swelling at the treatment site, and potential changes in skin pigmentation.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
I have been diagnosed with a type of hair loss due to genetics or scarring in the last 6 months.

Exclusion Criteria

You may be eligible for the trial if you check “No” for criteria below:
Select...
I haven't taken immunosuppressive drugs in the last 6 months.
Select...
I haven't had surgery in the treatment area in the last year or any major surgery in the last 6 months.
Select...
I have a history of high cholesterol, diabetes, hepatitis, or bleeding disorders.
Select...
I have a type of hair loss condition affecting my scalp.
Select...
I am unable to give consent for the study on my own.
Select...
I have not had chemotherapy in the last 12 months and do not have an immune deficiency.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~month 15
This trial's timeline: 3 weeks for screening, Varies for treatment, and month 15 for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
Hair counts
Hair density
Live and Photographic assessment of hair loss
Secondary study objectives
Subject Satisfaction
Subject Satisfation

Trial Design

2Treatment groups
Experimental Treatment
Group I: Scarring AlopeciaExperimental Treatment1 Intervention
The parameters of the laser will be set according to optimal operation protocol and in accordance with guidelines set forth by Sciton. Each laser treatment will take approximately 10 to 15 minutes per subject to target scarring alopecia.
Group II: Androgenetic AlopeciaExperimental Treatment1 Intervention
The parameters of the laser will be set according to optimal operation protocol and in accordance with guidelines set forth by Sciton. Each laser treatment will take approximately 10 to 15 minutes per subject to target androgenetic alopecia.

Find a Location

Who is running the clinical trial?

Montefiore Medical CenterLead Sponsor
455 Previous Clinical Trials
583,057 Total Patients Enrolled
ScitonIndustry Sponsor
19 Previous Clinical Trials
1,352 Total Patients Enrolled
Kseniya Kobets, MDPrincipal InvestigatorAlbert Einstein College of Medicine Montefiore Medical Center
4 Previous Clinical Trials
65 Total Patients Enrolled

Media Library

Sciton HALO 1470nm Non-ablative laser (Nonablative Laser) Clinical Trial Eligibility Overview. Trial Name: NCT05460611 — N/A
Male Pattern Baldness Research Study Groups: Androgenetic Alopecia, Scarring Alopecia
Male Pattern Baldness Clinical Trial 2023: Sciton HALO 1470nm Non-ablative laser Highlights & Side Effects. Trial Name: NCT05460611 — N/A
Sciton HALO 1470nm Non-ablative laser (Nonablative Laser) 2023 Treatment Timeline for Medical Study. Trial Name: NCT05460611 — N/A
Male Pattern Baldness Patient Testimony for trial: Trial Name: NCT05460611 — N/A
~6 spots leftby Dec 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top